세계의 테라노스틱스 시장

The global market for theranostics was valued at $3.7 billion in 2023. The market is expected to grow from $4.3 billion in 2024 to $12.7 billion by the end of 2029, at a compound annual growth rate, or CAGR, of 24.0% from 2024 to 2029.

The global market for theranostics equipment is expected to grow from $2.2 billion in 2024 to $3.6 billion by the end of 2029, at a CAGR of 9.7% from 2024 to 2029.

The global market for theranostics agents is expected to grow from $2.1 billion in 2024 to $9.1 billion by the end of 2029, at a CAGR of 34.5% from 2024 to 2029.

Report Scope:

This report provides a comprehensive summary of the theranostics market. It profiles all the major companies present in the market, including revenues, product portfolios and recent activities. It examines the competitive landscape, market trends and market dynamics such as drivers, restraints and opportunities. The report provides historic, current and projected market value. By product type, the market is segmented into theranostics equipment and theranostics agents. Theranostics equipment includes PET/CT, SPECT/CT and others; the theranostics agents studied are diagnostics and therapeutics agents. The regions considered are North America, Europe, Asia-Pacific, and the Rest of the World. The top countries in each region are also profiled. The market is also segmented by application.

Report Includes:

45 data tables and 37 additional tables

• An overview of the global markets for theranostics
• Analysis of trends in the global market for theranostics, with revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projected CAGRs through 2029
• Evaluation of the current market size and revenue growth prospects specific to theranostics, along with a market share analysis by product type, application, and region
• Assessment of current applications for theranostics and emerging applications such as macular degeneration, gynecology, cutaneous hypersensitivity and cardio-respiratory medicines
• Identification of technological and industry trends in each market segment, as well as the manufacturers of products used in theranostics, reagents and instrumentation for theranostics research, as well as suppliers of theranostics-related services
• Assessment of global R&D activity related to theranostics, resulting in the issuance of patents
• A discussion of ESG challenges and ESG practices in the industry
• Analysis of the key companies' market shares, proprietary technologies and strategic alliances
• Profiles of the leading players, including GE Healthcare, Siemens Healthineers AG, Novartis, Lantheus and Telix Pharmaceuticals Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• PESTLE Analysis
• Political
• Economic
• Social
• Technological
• Legal
• Environmental
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential of New Entrants
• Competition in the Industry
• Threat of Substitutes
• R&D and Regulatory Approval
• The Drug Development Process
• Drug Discovery
• Preclinical Development
• Clinical Trials
• The New Drug Application Review
• NDA Data Review
• Clinical Trials for Theranostics
• Steps Followed for Radiotherapeutics in Clinical Trials

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Theranostics Replacing Conventional Treatment
• Increased Application of Theranostics in Drug Discovery
• Prevalence of Chronic Diseases is Increasing the Demand for Personalized Treatment
• New Radiotheranostics Driving the Theranostics Market
• Rise in Chronic Inflammatory Diseases
• Cancer Epidemics in Developing Countries
• Market Restraints
• High Cost of Theranostics
• Market Challenges
• Nanotheranostics-Bio Interactions
• Challenges of Radiotheranostics
• Failure of Radiotherapeutics
• Market Opportunities
• Theranostics in Cardiovascular Diseases

Chapter 4 Emerging Technologies and Developments

• Artificial Intelligence in Theranostics
• Drug Delivery Using Innovative Material
• Boron Neutron Capture Therapy (BNCT)
• Luminogen Aggregation-Induced Emission (AIE)
• Theranostics in Rheumatoid Arthritis (RA)

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Product Type
• Theranostics Equipment
• Theranostics Agents
• Diagnostics Theranostics Agents
• Therapeutics Theranostics Agents
• Market Analysis, by Application
• Etiology of Cancer
• Cancer Diagnosis
• Cancer Therapeutics
• Prostate Cancer
• Neuroendocrine Tumors
• Thyroid Cancer
• Neuroblastoma
• Other Diseases
• Geographic Breakdown
• Market Analysis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Strategic Analysis
• Clinical Trials Analysis

Chapter 7 Sustainability in Theranostics Market: An ESG Perspective

• Introduction to ESG
• Key ESG Issues in the Theranostics Market
• Safety of Personnel
• Disposal of Radioactive Waste
• Nanopollution
• Current Status of ESG in the Theranostics Market
• ESG Performance Analysis
• Concluding Remark from BCC Research

Chapter 8 Appendix

• Methodology
• Sources
• Acronyms
• Company Profiles
• BAYER AG
• CURIUM PHARMA
• GE HEALTHCARE
• LANTHEUS
• NOVARTIS AG
• SIEMENS HEALTHINEERS AG
• TELIX PHARMACEUTICALS LTD.
• Other Companies